According to preliminary statistics of its financial department, Guangzhou Kingmed Diagnostics Group Co., Ltd. predicts that the net profit belonging to shareholders of the listed company in 2019 will be between RMB 380,000,000 and RMB 400,000,000 with an increase of between RMB 146,678,600 and RMB 166,678,600 and an increase of between 62.87% and 71.44% compared with the same period of the year before. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss in 2019 will be between RMB 295,000,000 and RMB 315,000,000 with an increase of between RMB 104,461,500 and RMB 124,461,500 and an increase of between 54.82% and 65.32% compared with the same period of the year before.